Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
398.2 USD | -0.65% | +0.83% | -2.49% |
12:26pm | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $497 From $515 | MT |
Apr. 23 | Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.49% | 104B | |
+1.36% | 97.42B | |
+0.79% | 22.2B | |
-17.85% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-15.97% | 15.06B | |
+3.83% | 13.98B | |
+34.47% | 11.66B | |
-26.03% | 8.22B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Vertex Pharma's Drug Candidate Improves Blood Glucose Control in Phase 1/2 Type 1 Diabetes Trial